GeneDx Holdings Corp. (WGS)
Sequences DNA to diagnose rare genetic diseases in children
$63.61+0.05%Healthcare
StockGlow Score
Leaning Bullish
BearishBullish
1 year ago-37.4%
The outlook
WGS is trading near its 52-week lows with a Strong Buy consensus from analysts, whose average price target sits about 29% above the current price. The stock shows mixed performance relative to its moving averages, reflecting near-term volatility despite the bullish analyst lean.
What’s behind the score
Analyst consensusStrong Buy — 1.1 avg of 9 analysts
Price trendMixed vs its moving averages
52-week range23% of the way from its 52-week low to high
Price targetAvg target +29% vs current price
Analyst price target
~12-month · 9 analysts$81.78average target+28.6% vs now
Now $63.61
Low $63.00High $100.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$1.89B
52-wk high
$170.87
52-wk low
$32.21
50-day avg
$58.08
200-day avg
$92.20
Trailing P/E
—